The chemotherapy-induced peripheral neuropathy market is emerging as a high-value market opportunity driven by the lack of approved therapies and the significant unmet clinical need. Rising global ...

The key opportunities in the chemotherapy-induced peripheral neuropathy treatment market include focusing on neurotransmitter ...

A French-American team reports that Carba1 prevents chemotherapy-induced neuropathy in preclinical models while preserving ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why ...

Many adults with diabetes and the associated complication of peripheral neuropathy, which can be painful as well as harmful, are often prescribed drugs at doses and for durations that could impose an ...

More than 20 million Americans are affected by peripheral neuropathy – often struggling to find real, lasting relief. Many people put off treatment, ...

Neuropathy affects about 25 million Americans today. Most solutions are medications that simply mask the problem and can ...

Diabetic peripheral neuropathy is a common complication of diabetes, often marked by pain, numbness, weakness and poor ...

Diabetic neuropathy can worsen over a period of many years. If it continues to progress, it can lead to potentially serious complications. Managing your blood sugar can help slow progression, ...

High blood sugar levels and your genes are among the main factors that can cause nerve damage in your hands, feet, and internal organs. Share on Pinterest Getty Images/Igor Alecsander Diabetic ...